ChartRow logo
Data provided bySource: Twelve Data
RPRX
$68.68+0.23%
as of close, Nov 17, 2026
☾ AH $68.68 +0.23%
Share this page

Royalty Pharma plc total returns by year (including dividends)

As of market close, Nov 17, 2026

Royalty Pharma plc annual returns by year
YearTotal return
2026YTD
+80.8%
2025
+55.3%
2024
-6.4%
2023
-27.1%
2022
+1.0%
2021
-19.1%
2020since Jun 16
+13.3%
Annualized
+7.9%
2021–2026
Average year
+0.7%
5 full years
Best year
+55.3%
2025
Worst year
-27.1%
2023
Positive years
2/5
40% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on RPRX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Royalty Pharma plc's average annual return?
Since 2021, Royalty Pharma plc (RPRX) has returned about 7.9% a year (the compound annual growth rate) and an average calendar-year return of 0.7%.
What were Royalty Pharma plc's best and worst years?
Over 2021–2026, the best year was 2025 (+55.3%) and the worst was 2023 (-27.1%).
How often is Royalty Pharma plc up in a year?
2 of the 5 full years since 2021 were positive — about 40% of the time.

More on Royalty Pharma plc